Skip to main content

Celera Genomics Narrows Loss

Click herefor an updated version of this story.


NEW YORK, July 23 - The Celera Genomics Group of Applera this morning reported a net loss of $19.4 million for its fourth quarter ending June 30, compared to a net loss of $28.8 million for the same period last year.


The Rockville, Md.-based company had revenues of $21.5 million for the quarter, compared to $28.1 million for the year-ago quarter.


The company had R&D expenses of $28.5 million, compared to $36.7 million for the fourth quarter of 2002.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.